1. Home
  2. JRSH vs KLRS Comparison

JRSH vs KLRS Comparison

Compare JRSH & KLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

HOLD

Current Price

$3.00

Market Cap

39.1M

ML Signal

HOLD

Logo Kalaris Therapeutics Inc.

KLRS

Kalaris Therapeutics Inc.

HOLD

Current Price

$6.12

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JRSH
KLRS
Founded
2016
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
46.0M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
JRSH
KLRS
Price
$3.00
$6.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$4.00
$20.67
AVG Volume (30 Days)
22.5K
41.4K
Earning Date
02-09-2026
03-17-2026
Dividend Yield
6.67%
N/A
EPS Growth
56.25
N/A
EPS
0.15
N/A
Revenue
$145,812,006.00
N/A
Revenue This Year
$11.64
N/A
Revenue Next Year
$10.06
N/A
P/E Ratio
$20.07
N/A
Revenue Growth
24.43
N/A
52 Week Low
$2.81
$2.14
52 Week High
$3.64
$11.88

Technical Indicators

Market Signals
Indicator
JRSH
KLRS
Relative Strength Index (RSI) 40.81 26.70
Support Level $2.87 $4.54
Resistance Level $3.16 $7.20
Average True Range (ATR) 0.10 0.77
MACD -0.01 -0.36
Stochastic Oscillator 43.77 4.04

Price Performance

Historical Comparison
JRSH
KLRS

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

About KLRS Kalaris Therapeutics Inc.

Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.

Share on Social Networks: